These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12052284)

  • 21. Warfarin or aspirin for recurrent ischemic stroke.
    Hsi DH; Alaimo DJ
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11951855
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anticoagulation and antiaggregation in neurological patients].
    Arnold M; Nedeltchev K; Mattle HP
    Ther Umsch; 2003 Jan; 60(1):33-5. PubMed ID: 12638476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB
    Cochrane Database Syst Rev; 2001; (1):CD001938. PubMed ID: 11279741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin and aspirin in patients with heart failure and sinus rhythm.
    Homma S; Thompson JL; Pullicino PM; Levin B; Freudenberger RS; Teerlink JR; Ammon SE; Graham S; Sacco RL; Mann DL; Mohr JP; Massie BM; Labovitz AJ; Anker SD; Lok DJ; Ponikowski P; Estol CJ; Lip GY; Di Tullio MR; Sanford AR; Mejia V; Gabriel AP; del Valle ML; Buchsbaum R;
    N Engl J Med; 2012 May; 366(20):1859-69. PubMed ID: 22551105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term anticoagulation or antiplatelet treatment. How do we decide between warfarin and aspirin?
    Cates C
    BMJ; 2001 Jul; 323(7306):235-6. PubMed ID: 11496890
    [No Abstract]   [Full Text] [Related]  

  • 26. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
    Hankey GJ
    Curr Opin Neurol; 2010 Feb; 23(1):65-72. PubMed ID: 19949330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined aspirin plus warfarin: recent evidence and residual questions.
    Donnan GA; Davis SM
    Stroke; 2009 May; 40(5):1946. PubMed ID: 19299633
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
    Furlan AJ
    Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635
    [No Abstract]   [Full Text] [Related]  

  • 30. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
    Rost NS; Giugliano RP; Ruff CT; Murphy SA; Crompton AE; Norden AD; Silverman S; Singhal AB; Nicolau JC; SomaRaju B; Mercuri MF; Antman EM; Braunwald E;
    Stroke; 2016 Aug; 47(8):2075-82. PubMed ID: 27387994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warfarin and aspirin for prevention of IHD.
    Zamorski MA
    J Fam Pract; 1998 May; 46(5):358-9. PubMed ID: 9597990
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticoagulation and platelet antiaggregation therapy in stroke prevention.
    Chong JY; Mohr JP
    Curr Opin Neurol; 2005 Feb; 18(1):53-7. PubMed ID: 15655403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.
    Akins PT; Feldman HA; Zoble RG; Newman D; Spitzer SG; Diener HC; Albers GW
    Stroke; 2007 Mar; 38(3):874-80. PubMed ID: 17255547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ever decreasing circles: advances in antiplatelet therapy and anticoagulation.
    Kennedy J; Buchan AM
    Stroke; 2003 Feb; 34(2):348-50. PubMed ID: 12574532
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.
    Athanasakis K; Boubouchairopoulou N; Karampli E; Tarantilis F; Savvari P; Bilitou A; Kyriopoulos J
    Am J Cardiovasc Drugs; 2017 Apr; 17(2):123-133. PubMed ID: 27882517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trials of newer approaches to anticoagulation in atrial fibrillation.
    Cooper HA
    J Interv Card Electrophysiol; 2004; 10 Suppl 1():27-31. PubMed ID: 14739737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin or aspirin for recurrent ischemic stroke.
    Lewis SC; Sandercock PA
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11948280
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome.
    Okuma H; Kitagawa Y; Yasuda T; Tokuoka K; Takagi S
    Int J Med Sci; 2009 Dec; 7(1):15-8. PubMed ID: 20046230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.
    Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP
    J Am Coll Cardiol; 2003 Sep; 42(6):1066-72. PubMed ID: 13678932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.